Appropriate laboratory investigation in women with menorrhagia;Bonne pratique et valeur diagnostique de la biologie: Hémostase- hématologie

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 37, Issue 8 SUPPL. 1, 2008, Pages

  De Raucourt, E ^a,b   Ternisien, C ^c  

^a CENTRE HOSPITALIER INTERCOMMUNAL   (France)

^b Mignot Hospital   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Anemia; Coagulation factor deficiency; Menorrhagia; Platelet functional defect; Von Willebrand disease

Indexed keywords

BLOOD CLOTTING FACTOR 8; RISTOCETIN;

BLOOD CELL COUNT; BLOOD CLOTTING FACTOR 11 DEFICIENCY; HEMOSTASIS; HUMAN; IRON DEFICIENCY ANEMIA; LABORATORY TEST; MENORRHAGIA; PARTIAL THROMBOPLASTIN TIME; PREVALENCE; PROTHROMBIN TIME; REVIEW; THROMBOCYTE AGGREGATION; THROMBOCYTE ANOMALY; THROMBOCYTOPENIA; VON WILLEBRAND DISEASE; ADOLESCENT; ADULT; ARTICLE; BLOOD; BLOOD CLOTTING DISORDER; CHILD; FEMALE; THROMBOCYTE DISORDER;

ADOLESCENT; ADULT; ANEMIA, IRON-DEFICIENCY; BLOOD COAGULATION DISORDERS; BLOOD PLATELET DISORDERS; CHILD; FACTOR XI DEFICIENCY; FEMALE; HEMOSTASIS; HUMANS; MENORRHAGIA; THROMBOCYTOPENIA; VON WILLEBRAND DISEASE;

EID: 69849084535     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0368-2315(08)74771-9     Document Type: Article

References (104)

1. Nichols WL, Hultin MB, James AH, Manco-Johnson MJ, Montgomery RR, Ortel TL, Rick ME, Sadler JE, Weinstein M, Yawn BP. Von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia 2008 Mar;14(2):171-232.
2. Castaman G, Federici AB, Rodeghiero F, Mannucci PM. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment. Haematologica 2003 Jan;88(1):94-108. Review.
3. Laffan M, Brown SA, Collins PW, Cumming AM, Hill FG, Keeling D, Peake IR, Pasi KJ. The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization. Haemophilia 2004 May;10(3):199-217. (Pubitemid 38584792)
4. Sadler JE, Rodeghiero F: ISTH SSC Subcommittee on von Willebrand Factor. Provisional criteria for the diagnosis of VWD type 1. J Thromb Haemost 2005 Apr;3(4):775-777
5. Favaloro EJ. The utility of the PFA-100 in the identification of von Willebrand disease: a concise review. Semin Thromb Hemost 2006 Jul;32(5):537-545
6. Plug I, Mauser-Bunschoten EP, Bröcker-Vriends AH, van Amstel HK, van der Bom JG, van Diemen-Homan JE, Willemse J, Rosendaal FR. Bleeding in carriers of hemophilia. Blood 2006 Jul 1;108(1):52-56 Epub 2006 Mar 21.
7. Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood 2004 Sep 1;104(5):1243-1252
8. Peyvandi F, Kaufman RJ, Seligsohn U, Salomon O, Bolton- Maggs PH, Spreafico M, Menegatti M, Palla R, Siboni S, Mannucci PM. Rare bleeding disorders. Haemophilia 2006 Jul;12 Suppl 3:137-142 Review.
9. Asakai R, Chung DW, Davie EW, Seligsohn U. Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med 1991 Jul 18;325 (3):153-158
10. Nurden P, Nurden AT. Congenital disorders associated with platelet dysfunctions. Thromb Haemost 2008 Feb;99(2):253-263 (Pubitemid 351230953)
11. Bolton-Maggs PH, Chalmers EA, Collins PW, Harrison P, Kitchen S, Liesner RJ, Minford A, Mumford AD, Parapia LA, Perry DJ, Watson SP, Wilde JT, Williams MD;UKHCDO. A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. Br J Haematol 2006 Dec; 135(5):603-633 Review. (Pubitemid 44674072)
12. Cattaneo M. Inherited platelet-based bleeding disorders. J Thromb Haemost 2003 Jul;1(7):1628-1636
13. Hayward CP, Rao AK, Cattaneo M. Congenital platelet disorders: overview of their mechanisms, diagnostic evaluation and treatment. Haemophilia 2006, Jul;12 Suppl 3:128-136
14. Rodeghiero F, Tosetto A, Castaman G. How to estimate bleeding risk in mild bleeding disorders. J Thromb Haemost 2007 Jul;5 Suppl 1:157-166 Review (Pubitemid 46958829)
15. Peyvandi F, Lak M, Mannucci PM. Factor XI deficiency in Iranians: its clinical manifestations in comparison with those of classic hemophilia. Haematologica 2002 May;87(5):512-514
16. Shankar M, Lee CA, Sabin CA, Economides DL, Kadir RA. Von Willebrand disease in women with menorrhagia: a systematic review. BJOG 2004 Jul;111(7):734-740 Review.
17. James AH, Lukes AS, Brancazio LR, Thames E, Ortel TL. Use of a new platelet function analyzer to detect von Willebrand disease in women with menorrhagia. Am J Obstet Gynecol 2004a Aug;191(2):449-455 (Pubitemid 39178697)
18. Saxena R, Gupta M, Gupta PK, Kashyap R, Choudhry VP, Bhargava M. Inherited bleeding disorders in Indian women with menorrhagia. Haemophilia 2003 Mar;9(2):193-196
19. Edlund M, Blombäck M, von Schoultz B, Andersson O. On the value of menorrhagia as a predictor for coagulation disorders. Am J Hematol 1996 Dec; 53(4):234-238 (Pubitemid 26419709)
20. Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998 Feb 14;351(9101):485-489
21. Dilley A, Drews C, Miller C, Lally C, Austin H, Ramaswamy D, Lurye D, Evatt B.Von Willebrand disease and other inherited bleeding disorders in women withdiagnosed menorrhagia. Obstet Gynecol 2001 Apr;97(4):630-636 (Pubitemid 32241125)
22. Philipp CS, Dilley A, Miller CH, Evatt B, Baranwal A, Schwartz R, Bachmann G, Saidi P. Platelet functional defects in women with unexplained menorrhagia. J Thromb Haemost 2003 Mar;1(3):477-484
23. Philipp CS, Faiz A, Dowling N, Dilley A, Michaels LA, Ayers C, Miller CH, Bachmann G, Evatt B, Saidi P. Age and the prevalence of bleeding disorders in women with menorrhagia. Obstet Gynecol 2005a Jan;105(1):61-66
24. Philipp CS, Faiz A, Dowling NF, Beckman M, Owens S, Ayers C, Bachmann G. Development of a screening tool for identifying women with menorrhagia for hemostatic evaluation. Am J Obstet Gynecol 2008 Feb;198(2):163.e1-8
25. Trasi SA, Pathare AV, Shetty SD, Ghosh K, Salvi V, Mohanty D. The spectrum of bleeding disorders in women with menorrhagia: a report from Western India. Ann Hematol 2005 May;84(5):339-342
26. Veyradier A, Gervaise A, Boyer-Neumann C, Wolf M, Fernandez H. Screening for bleeding disorders in women with menorrhagia using a platelet function analyzer. J Thromb Haemost 2006 Feb;4(2):483-485
27. Philipp CS, Miller CH, Faiz A, Dilley A, Michaels LA, Ayers C, Bachmann G, Dowling N, Saidi P. Screening women with menorrhagia for underlying bleeding disorders: the utility of the platelet function analyser and bleeding time. Haemophilia 2005b Sep;11(5):497-503.
28. Harrison P, Robinson M, Liesner R, Khair K, Cohen H, Mackie I, Machin S. The PFA-100: a potential rapid screening tool for the assessment of platelet dysfunction. Clin Lab Haematol 2002 Aug;24(4):225-232
29. Hayward CP, Harrison P, Cattaneo M, Ortel TL, Rao AK. The Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost 2006 b Feb;4(2):312-319
30. Koscielny J, Kiesewetter H, von Tempelhoff GF. More on platelet function analyzer (PFA)-100 closure time in the evalua tion of platelet disorders and platelet function. J Thromb Haemost 2006 Jun;4(6):1426-7; discussion 1428-1434
31. Favaloro EJ. Investigating people with mucocutaneous bleeding suggestive of primary hemostatic defects: a low likelihood of a definitive diagnosis? Haematologica 2007 Mar;92(3):292-296
32. Quiroga T, Goycoolea M, Panes O, Aranda E, Martínez C, Belmont S, Muñoz B, Zúñiga P, Pereira J, Mezzano D. High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls. Haematologica 2007 Mar;92(3):357-365
33. Goddard AF, McIntyre AS, Scott BB. Guidelines for the management of iron deficiency anaemia. British Society of Gastroenterology. Gut 2000 Jun;46 Suppl 3-4:IV1-IV5.
34. Hallberg L, Högdahl AM, Nilsson L, Rybo G. Menstrual blood loss - a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand 1966;45(3):320-351 No abstract available.
35. McKenna DM, Dockeray CJ, McCann SR. Iron deficiency in premenopausal females. Ir Med J 1989 Jun;82(2):69-70.
36. Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL. Prevalence of iron deficiency in the United States. JAMA 1997 Mar 26;277(12):973-976
37. Janssen CA, Scholten PC, Heintz AP. A simple visual assessment technique to discriminate between menorrhagia andnormal menstrual blood loss. Obstet Gynecol 1995 Jun;85(6):977-982
38. Kadir RA, Economides DL, Sabin CA, Pollard D, Lee CA. Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders. Haemophilia 1999 Jan;5(1):40-48
39. Kouides PA, Phatak PD, Burkart P, Braggins C, Cox C, Bernstein Z, Belling L, Holmberg P, MacLaughlin W, Howard F. Gynaecological and obstetrical morbidity in women with type I vonWillebrand disease: results of a patient survey. Haemophilia 2000a Nov;6(6):643-648
40. Lee CA, Chi C, Pavord SR, Bolton-Maggs PH, Pollard D, Hinchcliffe- Wood A, Kadir RA; UK Haemophilia Centre Doctors' Organization. The obstetric and gynaecological management of women with inherited bleeding disorders - review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors' Organization. Haemophilia 2006 Jul;12(4):301-336
41. Beck EA, Limoni C. Subnormal plasma von Willebrand factor (ristocetin cofactor) and iron deficiency anaemia in menstruating women. Thromb Haemost 1996 Apr;75(4):693.
42. Lewis GJ. Do women with menorrhagia need iron. Br Med J (Clin Res Ed) 1982 Apr 17;284(6323):1158.
43. Anonymous. Serum ferritin. The Lancet 1979;31:1-3.
44. Rodenberg RE, Gustafson S. Iron as an ergogenic aid: ironclad evidence? Curr Sports Med Rep 2007 Jul;6(4):258-264
45. Brownlie T 4th, Utermohlen V, Hinton PS, Giordano C, Haas JD. Marginal iron deficiency without anemia impairs aerobic adaptation among previously untrained women. Am J Clin Nutr 2002 Apr;75(4):734-742
46. Brutsaert TD, Hernandez-Cordero S, Rivera J, Viola T, Hughes G, Haas JD. Iron supplementation improves progressive fatigue resistance during dynamic knee extensor exercise in iron-depleted, nonanemic women. Am J Clin Nutr 2003 Feb;77(2):441-448 (Pubitemid 36133388)
47. Cook JD. Diagnosis and management of iron-deficiency anaemia. Best Pract Res Clin Haematol 2005 Jun;18(2):319-332
48. Srámek A, Eikenboom JC, Briët E, Vandenbroucke JP, Rosendaal FR. Usefulness of patient interview in bleeding disorders. Arch Intern Med 1995 Jul 10;155(13):1409-1415
49. Drews CD, Dilley AB, Lally C, Beckman MG, Evatt B. Screening questions to identify women with von Willebrand disease. J Am Med Womens Assoc 2002 Fall;57(4):217-218
50. Rodeghiero F, Castaman G, Tosetto A, Batlle J, Baudo F, Cappelletti A, Casana P, De Bosch N, Eikenboom JC, Federici AB, Lethagen S, Linari S, Srivastava A. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study. J Thromb Haemost 2005 Dec;3(12):2619-2626 (Pubitemid 41819788)
51. Tosetto A, Rodeghiero F, Castaman G, Goodeve A, Federici AB, Batlle J, MeyerD, Fressinaud E, Mazurier C, Goudemand J, Eikenboom J, Schneppenheim R, Budde U, Ingerslev J, Vorlova Z, Habart D, Holmberg L, Lethagen S, Pasi J, Hill F, PeakeI. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost 2006 Apr;4(4):766-773
52. Castaman G, Rodeghiero F, Tosetto A, Cappelletti A, Baudo F, Eikenboom JC, Federici AB, Lethagen S, Linari S, Lusher J, Nishino M, Petrini P, Srivastava A, Ungerstedt JS. Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study. J Thromb Haemost 2006 Oct;4(10):2164-2169 (Pubitemid 44400291)
53. Rodeghiero F. Management of menorrhagia in women with inherited bleeding disorders: general principles and use of desmopressin. Haemophilia 2008 Jan; 14 Suppl 1:21-30.
54. James A, Matchar DB, Myers ER. Testing for von Willebrand disease in women with menorrhagia: a systematic review. Obstet Gynecol 2004b Aug;104(2):381-388
55. Kadir RA, Lukes AS, Kouides PA, Fernandez H, Goudemand J. Management of excessive menstrual bleeding in women with hemostatic disorders. Fertil Steril 2005 Nov;84(5): 1352-1359
56. Lukes AS, Kadir RA, Peyvandi F, Kouides PA. Disorders of hemostasis and excessive menstrual bleeding: prevalence and clinical impact. Fertil Steril 2005 Nov;84(5):1338-1344
57. Presley AP. Do women with menorrhagia need iron? Br Med J (Clin Res Ed) 1982 Jun 19;284 (6332):1874.
58. Royal College of Obstetricians and Gynaecologists Mennorrhagia Guideline Group. The initial Management of Menorraghia. London: RCOG, 1998.
59. Royal College of Obstetricians and Gynaecologists Evidence-based Clinical Guidelines. The Management of Menorraghia in Secondary care. 2001 (Guideline no.5). Available at: htpp:// www.rcog.org.uk
60. Kouides PA, Conard J, Peyvandi F, Lukes A, Kadir R. Hemostasis and menstruation: appropriate investigation for underlying disorders of hemostasis in women with excessive menstrual bleeding. Fertil Steril 2005 Nov;84(5):1345-1351 Review.
61. Silwer J. Von Willebrand's disease in Sweden. Acta Paediatr Scand Suppl 1973;238:1-159.
62. Perry JJ, Alving BM. Von Willebrand's disease. Am Fam Physician 1990 Jan;41(1):219-224
63. Greer IA, Lowe GD, Walker JJ, Forbes CD. Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. Br J Obstet Gynaecol 1991 Sep;98(9):909-918
64. Foster PA. The reproductive health of women with von Willebrand Disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 1995 Aug;74(2):784-790
65. Ragni MV, Bontempo FA, Hassett AC. Von Willebrand disease and bleeding in women. Haemophilia 1999 Sep;5(5):313-317 (Pubitemid 29495707)
66. Kadir RA, Economides DL, Sabin CA, Pollard D, Lee CA. Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders. Haemophilia 1999 Jan;5(1):40-48 (Pubitemid 29094902)
67. Lak M, Peyvandi F, Mannucci PM. Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease. Br J Haematol 2000 Dec;111(4):1236-1239 (Pubitemid 32104944)
68. Woods AI, Meschengieser SS, Blanco AN, Salviú MJ, Farías CE, Kempfer AC, Lazzari MA. Clinical features and laboratory patterns in a cohort of consecutive Argentinian patients with von Willebrand's disease. Haematologica 2001 Apr;86(4):420-427
69. Kirtava A, Drews C, Lally C, Dilley A, Evatt B. Medical, reproductive and psychosocial experiences of women diagnosed with vonWillebrand's disease receiving care in haemophilia treatment centres: a case-control study. Haemophilia 2003 May;9(3):292-297 (Pubitemid 36622031)
70. Federici AB. Clinical diagnosis of von Willebrand disease. Haemophilia 2004 Oct;10 Suppl 4:169-176
71. Mauser Bunschoten EP, van Houwelingen JC, Sjamsoedin Visser EJ, van Dijken PJ, Kok AJ, Sixma JJ. Bleeding symptoms in carriers of hemophilia A and B. Thromb Haemost 1988 Jun 16;59(3):349-352
72. Yang MY, Ragni MV. Clinical manifestations and management of labor and delivery in women with factor IX deficiency. Haemophilia. 2004 Sep;10(5):483-490
73. Lak M, Keihani M, Elahi F, Peyvandi F, Mannucci PM. Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia. Br J Haematol 1999 Oct;107(1):204-206 (Pubitemid 29500827)
74. Bolton-Maggs PH, Patterson DA, Wensley RT, Tuddenham EG. Definition of the bleeding tendency in factor XI-deficient kindreds- a clinical and laboratory study. Thromb Haemost 1995 Feb;73(2):194-202.
75. Akhavan S, Mannucci PM, Lak M, Mancuso G, Mazzucconi MG, Rocino A, Jenkins PV, Perkins SJ. Identification and three-dimensional structural analysis of nine novel mutations in patients with prothrombin deficiency. Thromb Haemost 2000 Dec;84(6):989-997
76. Lak M, Sharifian R, Peyvandi F, Mannucci PM. Symptoms of inherited factor V deficiency in 35 Iranian patients. Br J Haematol 1998 Dec;103(4):1067-1069 (Pubitemid 29012645)
77. Peyvandi F, Tuddenham EG, Akhtari AM, Lak M, Mannucci PM. Bleeding symptoms in 27 Iranian patients with the combined deficiency of factor V and factor VIII. Br J Haematol 1998 Mar;100(4):773-776 (Pubitemid 28126114)
78. Shetty S, Madkaikar M, Nair S, Pawar A, Baindur S, Pathare A, Ghosh K, Mohanty D. Combined factor V and VIII deficiency in Indian population. Haemophilia 2000 Sep; 6(5):504-507
79. Seligsohn U, Zivelin A, Zwang E. Combined factor V and factor VIII deficiency among non-Ashkenazi Jews. N Engl J Med 1982 Nov 4;307(19):1191-1195 (Pubitemid 12037981)
80. Peyvandi F, Mannucci PM, Lak M, Abdoullahi M, Zeinali S, Sharifian R, Perry D. Congenital factor X deficiency: spectrum of bleeding symptoms in 32 Iranian patients. Br J Haematol 1998 Jul;102(2):626-628 (Pubitemid 28346611)
81. Karimi M, Menegatti M, Afrasiabi A, Sarikhani S, Peyvandi F. Phenotype and genotype report on homozygous and heterozygous patients with congenital factor X deficiency. Haematologica 2008 Jun;93(6):934-938
82. Lak M, Peyvandi F, Ali Sharifian A, Karimi K, Mannucci PM. Pattern of symptoms in 93 Iranian patients with severe factor XIII deficiency. J Thromb Haemost 2003 Aug;1(8):1852-1853
83. Burrows RF, Ray JG, Burrows EA. Bleeding risk and reproductive capacity among patients with factor XIII deficiency: a case presentation and review of the literature. Obstet Gynecol Surv 2000 Feb;55(2):103-108
84. Kulkarni A, Lee A, Griffeon A, Kadir A. Disorders of menstruation and their effect on the quality of kife in women with congenital factor VII deficiency. Haemophilia 2006;12:248-252.
85. Batorova A, Schved J, Auerswald G, Herrmann F, Peyvandi F, Dolce A, Bernardi F, Mariani G. Gynaecological Bleeding in congenital Factor VII deficiency. J Thromb Haemost 2007;5sup 2:P-S-005.
86. Mariani G, Herrmann FH, Dolce A, Batorova A, Etro D, Peyvandi F, Wulff K, Schved JF, Auerswald G, Ingerslev J, Bernardi F. International Factor VII. Deficiency Study Group. Clinical phenotypes and factor VII genotype in congenital factor VII deficiency. Thromb Haemost 2005 Mar;93(3):481-487
87. George JN, Caen JP, Nurden AT. Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood 1990 Apr 1;75(7):1383-1395 Review.
88. Lopez JA, Andrews RK, Afshar-Kharghan V, Berndt MC. Bernard- Soulier syndrome. Blood 1998;91:4397-4418.
89. Woo YL, White B, Corbally R, Byrne M, O'Connell N, O'Shea E, Sheppard BL, Bonnar J, Smith OP. Von Willebrand's disease: an important cause of dysfunctional uterine bleeding. Blood Coagul Fibrinolysis 2002 Mar;13(2):89-93.
90. Krause M, Aygoren-Pursun E, Ehrenforth S, Ludwig G, Vith TH, Scharr I. Coagulation disorders in women with menorraghia. Haemophilia 2000a; 6: 240-247.
91. Kouides P, Phatak P, Sham R et al. The prevalence of subnormal von Willebrand factor levels in menorraghia patients in Rochetser NY : a final analysis. Haemophilia 2000b:240-247
92. Hambleton J, Roth J, Jurnack-Dewell J, Schwartz B, Sermetis S. Prevalence of von Willebrand disease in women with menorrhagia: a preliminary report. Haemophilia 2000;6:240-247
93. Goodman-Gruen D, Hollenbach K. The Prevalence of von Willebrand disease in women with abnormal uterine bleeding. J Womens Health Gend Based Med 2001 Sep;10(7):677-680 (Pubitemid 32976205)
94. Baindur S, Shetty S, Pathare AV, Salvi V, Ghosh K, Mohanty D. Screening for von Willebrand disease in ptients with menorrhagia. Haemophilia 2000;6:240-247
95. El Ekiaby, Ahmed A, Farag O, Khattab D. Von Willebrand disease as a cause of menorraghia. Haemophilia 2002;8:512-514
96. Claessens EA, Cowell CA. Acute adolescent menorrhagia. Am J Obstet Gynecol 1981 Feb 1;139(3):277-280
97. Oral E, Ca da-A, Gezer A, Kaleli S, Aydin Y, Oçer F. Hematological abnormalities in adolescent menorrhagia. Arch Gynecol Obstet 2002 Apr;266(2):72-74
98. Smith YR, Quint EH, Hertzberg RB. Menorrhagia in adolescents requiring hospitalization. J Pediatr Adolesc Gynecol 1998 Feb;11(1):13-15
99. Bevan JA, Maloney KW, Hillery CA, Gill JC, Montgomery RR, Scott JP. Bleeding disorders: a common cause of menorrhagia in adolescents. J Pediatr 2001 Jun;138(6):856-861
100. Jayasinghe Y, Moore P, Donath S, Campbell J, Monagle P, Grover S. Bleeding disorders in teenagers presenting with menorrhagia. Aust N Z J Obstet Gynaecol 2005 Oct;45(5): 439-443 (Pubitemid 41830370)
101. Mikhail S, Varadarajan R, Kouides P. The prevalence of disorders of haemostasis in adolescents with menorrhagia referred to a haemophilia treatment centre. Haemophilia 2007 Sep;13 (5):627-632
102. Gouault-Heilmann M, Ajzenberg N, Alhenc-Gelas M, Conard J, Dreyfus M, Verdy E. Recommandations pour une juste prescription des examens d'hémostase en pratique médicale courante. STV 2006;18:29-42. (Pubitemid 43206823)
103. Blomback M. Scientific visits to the Alands Islands. Haemophilia 1999 (suppl 2)p:12-18.
104. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L. Maturation of the Hemostatic system during chilhood. Blood 1992;80:1998-2005.